All In Nutritionals
Home Blog Page 121

The Redwood Group, LLC Completes Its Acquisition Of Ceres Commodities, LLC

0

For over 20 years, Ceres Commodities has supplied premium food-grade non-GMO and organic soybeans and other commodities domestically as well as directly into East and Southeast Asian food markets. The Ceres Commodities team’s intimate knowledge of the food soy export market complements Redwood’s ability to continually supply a superior quality product to those markets through its network of non-GMO soybean cleaning facilities.

“We have developed a wonderful relationship with Redwood over the past few years and we look forward to combining our deep customer relationships and logistics expertise with Redwood’s existing business. Our customers can continue to expect excellent service as well as the additional value that we can provide to our buyers and suppliers by leveraging Redwood’s efficient, customer-focused business model as well as their systems and strong balance sheet,” stated Chris Bradley, the previous owner of Ceres Commodities, LLC.

“The Ceres Commodities business is an excellent extension of our Lathrop FSG operations. Lathrop FSG offers a closed-loop supply chain solution, selling seed to its non-GMO soybean growers, purchasing commodity back from those growers, and then cleaning and packaging products to customer specifications. The acquisition of Ceres Commodities further allows us to manage the supply chain to ensure our customers receive the best quality product when they need it,” said Mike Kincaid, President of The Redwood Group, LLC.

The Redwood Group, LLC is an employee-owned supply chain, merchandising and a solutions-based company that focuses on food ingredients, feed ingredients, and energy products.  It is headquartered in Mission, KS, with additional office locations in Omaha, NE and Newport, KY, and with specialized cleaning facilities located in Chester, MTVenango, NELathrop, MO and Pleasant Hill, MO.  Redwood was formed in 2010 with a focus on offering a wide variety of high-quality products and superior customer service.  Redwood purchases and supplies products throughout the United States and Canada as well as imports and exports products to and from customers around the globe.

Protein Industries Canada will begin accepting Expressions of Interests (EOIs) for its second call for proposals on September 1, 2019.

0

“We are excited to issue our second call for proposals as we keep working to advance the value-added processing sector in Western Canada to increase the production of plant protein-based products and co-products.” Chief Executive Officer of Protein Industries Canada Bill Greuel said. “We will once again be accepting EOIs aligned with our strategic objectives in our priority pillars of Create, Grow, Make and Sell.  In addition to creative new uses for proteins and protein products, we hope to see projects related to co-product uses like livestock feed and starch utilization.”

All projects must be submitted by a consortium consisting of at least two Protein Industries Canada members, one of which must be a Small and Medium Enterprise (SME). Projects must demonstrate collaboration between organizations to leverage strengths, address gaps and incent innovation to accelerate the processing of plant protein products and co-products.

“We had an overwhelming response to our first call for proposals that closed at the end of June, receiving 38 expressions of interests,” Greuel said. “This demonstrates the interest in plant protein and the strength of the sector.  We look forward to working with companies of all sizes from across Canada and globally to capitalize on the growing opportunity for plant protein.”

Of the 38 EOIs received in the first round, 16 have been invited to the full project proposal phase. Of the 16 EOIs that proceeded to full project application, 17 per-cent fall into the create category, 11 per-cent into growing, 69 per-cent into making and three percent into selling.  Pulse crops were the main commodity in more than half the projects, followed by canola, hemp and cereals. The value of the 38 projects submitted totalled more than $300 million.

In addition to investing in technology projects, Protein Industries Canada will also invest approximately 12 per-cent of its budget into eight ecosystem priorities: Regulatory Reform; Indigenous Engagement; Talent and Skills; IP Literacy; Data and ICT Management; Global Brand and Trade; Infrastructure Enhancement and Access to Capital. There will not be an open call for these projects, but instead targeted requests to fill identified gaps and needs.

Slovakian Doctor Takes 42 Diabetics Off Medication – With The NFI Protocol

0
Dr. Janka Lejavova, MD

A Slovakian doctor has taken 42 of her type 2 diabetes patients off medication – using an advanced plant-based protocol.

Under the guidance of Dr. Janka Lejavova, MD., the patients followed the Natural Food Interaction (NFI) protocol, a whole-food, a plant-based approach that mixes and matches different plant foods in combinations that are tailored to an individual.

The protocol, which was founded by David Hickman and Zuzana Plevova, has yielded impressive results in trials so far, with a 96.5 percent type 2 diabetes remission rate in patients that have completed the protocol.

Patient success

Among Dr. Lejavova’s success stories was Tereza G, a 33-year-old who has been diabetic for three years. After 13 weeks on the protocol, she lost 15kg and brought her blood glucose into the normal range.

Tereza was worried about having a child with type 2 diabetes, so Dr. Lejavova guided her through treatment, so she would feel in a better situation for potentially having a child.

Another patient, Edward T had struggled for years, trying various diets, and finding nothing helped. After 17 weeks on the protocol, he lost 21kg and was taken off his medication.

In addition, a further 50 patients are due to come off medication in the next month, based on the number of patients following the diet. A total of 600 patients are currently following the NFI protocol from all over the world.

Improving their lives

“I’m really pleased that these patients were able to improve their lives, the NFI Protocol is a method to reverse Type 2 diabetes, but in the end, it is always up to the patient,” David Hickman told Plant Based News.

“Everybody at NFI is always really happy for anyone willing to make a genuine change to their health. We are just happy to be part of their journey.

“The NFI Protocol works for anyone, but it is always up to the patient how exactly they will stick to their personal protocol.”

‘A special feeling’

“It is a really special feeling being able to share the success of this protocol,” added Dr. Janka Lejavova.

“After feeling disillusioned over the last 12 years working in the medical field, I have hope back.

“The NFI diet has not just reminded me why I got into medicine – but allowed me to take action. I’m so delighted I am now able to help patients achieve true health.”

NFI meal plans are available to the public

You can find out more about the NFI diet here, including testimonials. The public can purchase NFI meal plans here.

Type 1 Diabetes and my Vegan Lifestyle | Abby David

0

At that point in my life, I basically didn’t care about anything that didn’t affect me directly… at all.Another part of the reason I would’ve said no is because of my type 1 diabetes. I was under the impression that a vegan diet was all carbs and no flexibility. If you don’t know what type 1 diabetes is, then let me first explain. Type 1 is an autoimmune condition where your body attacks the cells in the pancreas that produce insulin. Type 1 is NOT preventable or manageable by just diet and exercise. In every case, the person affected must take insulin in some form for the rest of their life, whether it be through injections or an insulin pump is up to the individual. About 5% of humans affected by diabetes have type 1. The other 95% have type 2. Type 2 diabetes is the one you hear about a lot more. This type can be controlled by diet and exercise and is the kind you see all the commercials about. When people say “diabetes is becoming an epidemic” and other comments like that, they’re talking about type 2 whether they know it or not. Getting diagnosed with type 1 at the age of 16 was life-changing, to say the least.

At the beginning of the journey, I followed exactly what the Canadian diabetes association told me to do. Eat 5-6 times a day, with the same amount of carbs at each meal and snack. They told me eventually I could be more flexible. They told me to eat whatever I wanted as long as I knew the carb count and it was in range with my regiment. They never told me to eat low carb and they actually had me eating over 150 grams of carbs a day. In the hospital, they fed me so many processed foods like packaged cookies, sugary yogurt, jello, sandwiches… the list goes on. I understand they were doing this because boxed food had exact carb counts on it, but it definitely is not a healthy way to approach food. I ate like this for the first 4 years of my diagnosis, counting carbs on boxed food and avoiding healthy grains, veggies, and fruits.

Fast forward to my third year of college, I had come to a breaking point with my diabetes. I felt so extremely out of control and I was having major spikes and crashes every day. I felt lost and defeated and started missing class and bailing on friends. I began to search for an answer. The only one I could come up with was eating an extremely restrictive low carb high protein/fat diet (which ended up being almost all animal products); this diet included a lot of meat, cheese, and high-fat dairy.

However soon my energy began to fade and my digestive system became completely out of wack, I slowly started to feel like my way of being wasn’t helping my health anymore. Around this same time, I started becoming interested in whole-food, plant-based living. I was initially nervous to take the leap though because of how it might affect my diabetes. But the more research I did on plant-based living and veganism, the more pull I felt towards it. Amazingly -to my surprise- my diabetes cooperated with this new diet. All of a sudden after a week or two of eating vegan I barely had any insulin resistance (which meant I could eat more carbs and give myself less insulin than before).

I was also able to eat with more flexibility without having spikes or crashes. I was filling my body with so many more vegetables, whole grains, and nutrient-dense foods, and my body was thanking me. My energy levels increased and my digestive system went back to normal – I was so happy. The true tipping point was watching the movie Earthlings. If you haven’t seen it you should probably give it a watch, it’s important to stay informed about where your meat comes from and what truly goes on behind closed doors at factory farms. That was 2 years ago and the next day I was completely vegan and I haven’t looked back.

My previously lower thyroid reading was up at a better number as well. I felt completely elated that my new way of living didn’t make my blood sugar worse, but actually better. Even though I do eat more carbs then I used to, I still stick to a moderately low carb diet, that’s just what has worked best for me personally.

There is a group of type 1 diabetics who eat high carb plant-based (extremely low fat) and I did try that eating that way for a bit. Unfortunately, it led to a lot of inconsistent numbers for me and gave me lots of mood swings. For now, I stick to lots of veggies, good fats, protein, and complex carbs. I try to reduce the amount of processed food I eat as well.

Even though my blood sugar is under control 95% of the time, finding a perfect diet for type 1 diabetes will never be possible because food is not the only thing that affects blood sugar. Some other factors are exercise, hormones, sleep, stress, the act of waking up, and so many more. One of the reasons I’m so happy with eating plant-based is because I know its healing the rest of my body as well. I’m taking care of my health as a whole instead of just one aspect. Now that you know my story, here are some pointers I would give to anyone looking to switch to a plant-based diet who are concerned about their blood sugar.

By Abby David
Source: www.plantbasedtoronto.com

Cosmetic Laser Market is Predicted to Boost its Value by year 2026

0

It is used for treating many medical conditions such as aging skin problems, age spots, fine lines, and wrinkles on the face birthmarks, spider veins, droopy, dry, sagging eyelid skin, and dark circles. Further, it can also be used in uneven skin tone correction and texture, smokers’ line, vascular lesions, and skin tightening.

Significant increase in the preference for non-aesthetic procedures and technical advancement in laser technology are the major factors that drive the Cosmetic laser market growth. In addition, surge in adoption of the non-invasive procedures, rise in cases of skin damages, increase in medical tourism & ever-changing lifestyles and reduced procedural expenses propel the cosmetic laser market growth. Other factors such as enhanced implementation of aesthetic procedures, development of laser technology, increased focus on body appearance among both men and women, high disposable income in developing economies fuel the market growth. However, factors such as less emphasis of manufacturers on aesthetic devices, strict regulations by the government on the usage of cosmetic lasers, and lack of reimbursement are anticipated to hamper the market growth. Conversely, development in fillers, lasers, and injectables are estimated to create lucrative opportunities for cosmetic laser market in the near future.

Several advancements have been witnessed in the recent years in laser and light-based devices. For instance, a new hair removal device called Soprano Titanium has been introduced by main players such as Alma Lasers. This device features new 4 cm spot-size Quattro 3D applicator handpiece, delivering three laser wavelengths: 755 nm, 810 nm, and 1064 nm to treat different types of skin. Cosmetic companies such as Candela and the Vascular Birthmarks Foundation have partnered together to provide pro-bono laser treatments. In addition, in 2018, Cutera introduced Pico genesis that helps in treating skin pigmentation, which also enhances the patient’s skin complexion.

The cosmetic laser market is segmented based on product, modality, application, end user, and region. On the basis of product, the market is segmented into ablative, non-ablative, and laser. Based on modality, the market is segregated into pulsed dye laser (PDL), YAG laser, carbon dioxide laser (CO2), Erbium, Intense pulsed light (IPL), radiofrequency, infrared, and others. Based on application, it is divided into hair removal, skin resurfacing, vascular lesions, scar and acne removal, body contouring, and others. Based on end user, it is classified into hospitals, skin care clinics, and cosmetic surgical centers. On the basis of region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The report provides a comprehensive analysis of the key players operating in the global cosmetic lasers market are Alma, Candela, Cutera, Cynosure, Deka, Hoyoconbio, Lumensis, Palomar, and Syneron, Aerolase El.En. Spa Lumenis Ltd., Aerolase Corporation Sciton, Inc., Sharp Light Technologies, Fosun Pharmaceutical, Syneron Medical Inc., and Solta Medical. The other players in the value chain include Aerolase Corporation, Iridex, ALLTEC GmbH, and Fotona.

Key Benefits for Stakeholders

  • The report provides an extensive analysis of the global cosmetic lasers market size, current market trends, and future estimations of the market.
  • The analysis is comprehensively covered with respect to the component, application, and region.
  • The growth estimations in this report are based on high-end analysis of the key developments for 2018–2026.
  • Recent developments, key manufacturers, and top player positioning are listed in this report to analyze the competitive scenario of the cosmetic laser market.

Key Market Segments

By Product 

  • Ablative
  • Non-ablative
  • Non-laser

By Modality 

  • Pulsed Dye Laser (PDL)
  • YAG Laser
  • Carbon Dioxide Laser
  • Erbium
  • Intense Pulsed Light (IPL)
  • Radiofrequency
  • Infrared
  • Others

By Application 

  • Hair Removal
  • Skin Resurfacing
  • Vascular Lesions
  • Scar and Acne Removal
  • Body Contouring
  • Others

By End User 

  • Hospitals
  • Skin Care Clinics
  • Cosmetic Surgical Centers

By Region

    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

Pneumonia Vaccine Market to face rise in demand by the end of year 2025

0

According to a new report published by Allied Market Research, titled, “Global Pneumonia Vaccine Market by Vaccine, Product, Sector, and Distribution Channel: Opportunity Analysis and Industry Forecast, 2018 – 2025,” the global pneumonia vaccine market is expected to reach $10,215 million by 2025, registering a CAGR of 5% from 2018 to 2025, in terms of value.

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, virus, or fungi; however, bacterial pneumonia is the most common form occurring in adults.

Pneumonia results in inflammation in the air sacs (known as alveoli) of the lungs, which results in filling the alveoli with fluid (pus cells), thus causing breathing problems. Pneumococcal disease is common in young children, but older adults are at greatest risk of serious pneumococcal infections and even death.

Pneumonia vaccines are primarily administered to children less than 2-years old and adults aged 65 years and older. This vaccine helps individuals provide immunization against 13 types of pneumococcal bacteria that causes infection in the lungs.

The key factors that drive the growth of the global pneumonia vaccine market include increase in prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and introduction of novel pneumococcal vaccines such as PCV10. However, longer timelines required for pneumonia vaccine production and high costs associated with development of such vaccines restrain the market growth. Development of protein-based combination pneumococcal vaccines is expected to offer lucrative opportunities for the expansion of this market during the forecast period.

Based on type, pneumococcal conjugate vaccine (PCV) is expected to maintain its dominant (more than half of the market share in 2017) position during the analysis period as it is been widely prescribed as compared to pneumococcal polysaccharide vaccine (PPV).

Based on product, the Prevnar 13 segment held the major market share in 2017 and is expected to dominate the market throughout the forecast period, owing to the wide usage and its efficiency in pneumonia prevention.

Based on distribution channel, the distribution partner companies segment held majority of the market share in 2017, owing to the wide coverage of the private entities. This segment is expected to dominate the market during the forecast period due to majority of private vaccines purchases which are comparatively expensive are distributed from these companies. Hence, the distribution partner companies hold larger share.

Based on sector, the private sector dominates the overall market for pneumonia vaccines and is expected to dominate the market throughout the forecast period due to the higher prices of the vaccine in the private market.

North America accounted for nearly three-fifth of the global market in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to the higher prevalence in the developing countries such as India and China, increase in government healthcare expenditure, rise in demand for better healthcare, and surge in number of childbirths in the region. Moreover, government support and development of protein-based combination pneumococcal vaccines are the factors expected to present new growth opportunities to the players in this market.

Key Findings of the Pneumonia Vaccine Market:

  • The pneumococcal conjugate vaccine (PCV) segment is expected to grow with a CAGR of 5.1% from 2017 to 2025.
  • Prevnar 13 vaccine is expected to be the fastest growing product with a CAGR of 5.1%.
  • The distribution partner companies held approximately half of the global market share and is expected to remain dominant throughout the forecast period.
  • The private segment held more than threeforth share in the global market and is expected to remain dominant throughout the forecast period.
  • Asia-Pacific is expected to be the fastest growing region, registering a CAGR of 6.6% during the forecast period.

The report provides an extensive competitive analysis and profiles of the key market players such as Glaxosmithkline plc., LG Chem Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited), SK Bioscience, and Walvax Biotechnology Co., Ltd.

Healthy Planet Celebrates Grand Opening of Four New Stores in Ancaster, Cambridge, Milton & Ajax

0

In addition to a sale of up to 70% off at each store location, customers can enjoy the festivities with some food, drinks, swag bags, and a social media contest with draws being held in-store for event attendees only. Prizes to be won include Healthy Planet gift cards, bicycles, Vitamixes and Fitbits.

There will be 100 swag bags available to be scooped at each location, on a first-come, first-served basis. For more information on these events or to learn more about Healthy Planet visit HealthyPlanetCanada.com or follow
@HealthyPlanetStore on Facebook, and
@HealthyPlanet on Instagram.

About Healthy Planet Canada
Healthy Planet started in 1995 and today is one of Canada’s fastest-growing health and wellness retail chains, with stores across Canada, and an online store that is open 24/7. Healthy Planet is passionate about sourcing the highest quality supplements, vitamins, sports nutrition, health foods, organic grocery, bath & beauty, and eco-friendly products at the lowest possible price. With a philosophy rooted in making the world healthier and greener, Healthy Planet takes great pride in aligning with socially responsible manufacturers and distributors to ensure its customers live their best and healthiest life.

To learn more about Healthy Planet visit HealthyPlanetCanada.com.

Sobeys says Voilà to online grocery delivery

0
Voilà by Sobeys and Voilà par IGA promises to help Canadians stay one step ahead of their busy lives, underscored by a new tag line “Your groceries delivered. Just like that.” (CNW Group/Empire Company Limited)

Parent Empire Company Ltd. said that the retailer’s initial home delivery offering, Voilà by Sobeys, is slated to get underway in the greater Toronto area and Ottawa in spring 2020 when its previously announced customer fulfillment center (CFC) in Vaughan, Ontario, begins operation.

Due to launch in 2021 is Voilà par IGA, an online grocery delivery service for major cities in Quebec that will be served by a second CFC to be built in Pointe-Claire, Montreal. The Sobeys and IGA Voilà services and the Vaughan and Montreal CFCs will be powered by Ocado’s Smart online grocery platform.

Sobeys and Ocado announced their partnership in January 2018. Plans call for the development of an e-commerce infrastructure enabling online grocery ordering, automated fulfillment, and home delivery. That includes front-end website functionality and mobile ordering; automated warehouses using Ocado’s grid and robots; last-mile routing management technology for delivery trucks; and customer service tools. The Voilà service will offer a selection of up to 39,000 products, including fresh produce, at prices comparable to those at Sobeys and IGA stores, Stellarton, Nova Scotia-based Empire said. The online grocery brand will carry the tagline “Your groceries delivered. Just like that.”

“We are building the most advanced e-commerce infrastructure in Canada,” Sarah Joyce, senior vice president of e-commerce for Empire, said in a statement. “An online grocery home delivery experience like Voilà by Sobeys does not yet exist in Canada. While most players in the industry are focused on store pick models to fulfill their online orders, we are building automated warehouses specifically designed for best-in-class home delivery based on a highly successful model from the U.K. Voilà by Sobeys will deliver Canadians exactly what they want, when they want it, every time.”

IGA has provided online grocery pickup and delivery in Quebec for more than 20 years via its IGA.net service. Empire said IGA.net will continue to offer online grocery service in Quebec until Voilà par IGA and the Montreal CFC launch in 2021. Thereafter, IGA.net will continue to serve customers outside the Voilà delivery area.

“We’re thrilled to build on our solid legacy of e-commerce in Quebec,” Joyce added. “When selecting future locations, we consider the size of the market, population density and potential for growth. Launching in Quebec is another exciting step forward to bringing the world’s most innovative e-commerce solution to Canadians.”

Construction of the Vaughan CFC is on schedule and will cost an estimated $95 million, Empire reported. The company said it expects the Montreal CFC’s construction cost to be about the same or possibly less than Vaughan’sVoilà since the latter facility enables efficiencies in Montreal. Empire plans to partner with its Crombie REIT subsidiary to develop the Montreal CFC and then lease the facility from Crombie.

Empire added that most of the Montreal investment will be incurred by Crombie, while software, licensing and systems integration costs incurred in fiscal 2019 will apply to both CFCs. The company said its e-commerce expansion will create about 1,500 jobs in the greater Toronto and Montreal areas.

Overall, Sobeys owns, affiliates or franchises more than 1,500 stores in all 10 provinces under such banners as Sobeys, Safeway, IGA, Foodland, FreshCo, Thrifty Foods, Farm Boy and Lawtons Drugs. Its retail network also includes 350-plus fuel locations.

Patented Curcumin BioBDMC30™, Manages Inflammation, Joint Pain and Discomfort

0

Biologic Pharmamedical announced today that it has received approval by Health Canada’s NNHPD and a Natural Product Number (NPN) for its market-proven Curcumin BioBDMC30™ and variable offshoot technologies including others with condition specific-indications. This research-supported, patented technology delivers an exceptionally high concentration – 30% – of bisdemethoxycurcumin (BDMC), which is designed to help manage inflammation, joint pain, and discomfort, and support recovery from day-to-day workouts or injuries utilizing very unique pharmacology that differentiates it significantly from regular curcumin 95%.

This highly potent anti-inflammatory offers 60x more BDMC than most products, providing immense joint pain relief and more rapid recovery from inflammation caused by injuries and exercise.  The recent discovery made in a Canadain laboratory as a function of more than a decade of research also exhibits a profound antioxidant potential never seen before on the planet jumping the ORAC value for Curcumin BioBDMC30™ to an unprecedented 1,130,000 mM/TE per 600 mg.

Curcumin BioBDMC30™ is based on research by Biologic Pharmamedical Research (www.biologic-med.com)  CEO, Franco Cavaleri BSc Ph.D. Candidate, who is also the principal research scientist at Biologic Pharmamedical. For the first time, Cavaleri’s research shows how the modified curcumin extracts targets and neutralizes a key protein central in the regulation of inflammation while significantly enhancing the anti-inflammatory properties of curcumin.  This genomic and proteomic research model was designed by this Canadian scientist to ultimately serve as a model that has shed light on the activity of other curcuminoids in the context of other important drug targets.

“Research shows that BDMC targets inflammation in a novel way inhibiting MSK1 an activation protein that turns on the production of inflammatory cytokines while regular curcumin simply cannot neutralize this protein,” said Cavaleri. “Instead of trace levels of BDMC, usually between 0.5% and 1.5%, in standard curcumin, we can now provide 30% BDMC and dramatically enhance anti-inflammatory relief, which could not be done reliably before.”  Cavaleri goes on to say. “Regular curcumin 95% can slow down NF-kB transcription protein activity but it cannot inhibit MSK1.”

This new curcumin research has demonstrated effective modulation of survival proteins in difficult to treat diseases. Regular curcumin inhibits only one key inflammatory protein of the two inflammatory proteins Curcumin BioBDMC30™ neutralizes. BDMC engineering is also revealing a faster symptom resolution time in cases of dysregulated inflammation and joint pain when compared to typical curcumin.

Cavaleri’s research at the Canadian-based Biologic Pharmamedical Research is focused on defining ways to improve clinical and research reliability using curcumin-based drugs as supplements or alternatives to glucocorticoids for glucocorticoid-resistant inflammatory diseases, and to chemotherapy for drug-resistant cancers. This Canadian researcher in the Canadian laboratory has changed the way the world now views and designs curcuminoid-based technologies. This discovery has set in motion multiple new findings related to new drug targets by the scientist for curcumin that leverages this curcuminoid engineering. A second technology relating to this isolated curcuminoid research about to be announced focusses in on cholesterol management with similar mechanisms to common statin drugs but without the side-effects. Cavaleri’s research in this field has recently been published in peer-reviewed publications further validating the novel findings and he says Biologic Pharmamedical Research has more exciting findings on other botanical agents relating to diabetes and obesity about to be made public.

Computers, not TV, are to blame for increase in US sitting time, study says

0
Work routine with computer is the reality of millions of people.

There’s a key culprit in the battle against sitting. Time spent watching TV and videos has remained consistently high in the United States over the past 15 years, but time sitting at a computer has increased dramatically, new research finds.

Leisure-time computer use increased between 4.8% and 38% for various age groups between 2001 and 2016, said Yin Cao, senior author of the new study and an assistant professor of surgery at Washington University School of Medicine in St. Louis. Overall, up to 43% of the US population used a computer for two or more hours a day and up to 25% used a computer for three or more hours each day in 2016. The result of these increases: Teens spent about 8.2 hours a day sitting while adults sat for 6.4 hours a day.

Both groups saw a one-hour increase over the decade ending in 2016, Cao said.
Cao believes that her research, published Tuesday in JAMA, will help Americans better understand our sedentary habits – and change them.

The habit to use a laptop computer at home.

Sitting trends over the past 15 years
“Research evidence has been growing on the association between sedentary behavior primarily TV watching and a variety of diseases, including obesity, cardiovascular disease, cancer, Type 2 diabetes and overall mortality,” Cao said.

For the first time, the US Department of Health and Human Services mentioned in last year’s edition of its physical activity guidelines “that people would benefit from both increasing moderate to vigorous activity and also reducing time spent sitting,” she said.
She wondered: How much do Americans sit, and how has the trend changed over the past 15 years? To answer these questions, Cao and her co-authors used data from the National Health and Nutrition Examination Survey on 51,896 people 10,359 children, 9,639 teens, and 31,898 adults from 2001 through 2016.

Overall, up to 65% of the population reported watching TV for at least two hours each day, the study found. “This is quite high and has been overall stable over the past 15 years,” Cao said. Computer time, though, has been increasing over that same period.

Just 43% of children reported using a computer for one hour per day or more in 2001; that rate increased to 56% in 2016, the study indicates. The estimated prevalence for teens increased from 53% to 57%, and for adults, it went from 29% to 50% between 2003 and 2016. Only adults and teens reported their total sitting time.

“Hopefully, this paper will be helpful in terms of setting the national achievable goal of reducing sitting, given that we already know prolonged sitting is bad for many health outcomes,” Cao said.

The new generations and technology.
Source: www.cnn.com